TAMS is focused on reducing healthcare related exposure to bloodborne pathogens. Our solutions are based on engineering controls—devices that effectively reduce the risk of exposure associated with needlestick injury and device reuse. Unfortunately, healthcare worker access to innovative products is often limited by contracts and entrenched market interests.
BLOODBORNE PATHOGEN EXPOSURES PLAGUING HEALTHCARE
Unsafe Safety Products
Safe in Name Only, some so-called "safety" needle devices are, in reality, just as dangerous as their non-safety predecessors; in fact, some are even more so. Some of these ill-conceived "safety" devices actually increase the number of needlestick injuries. Some clinicians, fearful of getting stuck, often intentionally don't activate the "safety" feature.
Worldwide needlestick injuries cause millions of exposures annually to HIV/AIDS, hepatitis B virus (HBV), hepatitis C virus (HCV), and many other bloodborne diseases. It is estimated that over 320,000 needlestick injuries occur every year in the United States. There are more than 20 bloodborne pathogens that can be transmitted by needlestick injuries.
Catheter-Related Bloodstream Infections
"Shortly after their introduction in the early 1990s, needleless connectors were associated with rising rates of CRBSI [catheter-related bloodstream infections]." The luer tip of a standard syringe is exposed to the risk of contact (or touch) contamination by healthcare personnel, as well as through contact with any unsterile surface. Since the luer tip directly interfaces with the access port, contamination of the luer tip has the potential for contaminating the access port and infusate, which increases the risk of nosocomial infections, such as bloodstream infections.
Syringe reuse is a worldwide problem and can result in the spread of bloodborne pathogens. The World Health Organization (WHO) estimates that 40% of the 16 billion injections administered worldwide annually involve reused, unsterilized syringes and needles, with rates of unsafe injections climbing to 70% in some countries. The reuse of injection equipment is responsible worldwide for 32% of new HBV infections, 40% of new HCV infections, and 5% of all new HIV infections.